Synthaverse S.A. (FRA:6NQ)

Germany · Delayed Price · Currency is EUR

0.6120

-0.0060 (-0.97%)

At close: Oct 23, 2026

Market Cap	46.98M -33.0%
Revenue (ttm)	11.34M -21.8%
Net Income	-4.88M
EPS	-0.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.6220
Previous Close	0.6180
Day's Range	0.6120 - 0.6220
52-Week Range	0.5930 - 1.0020
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2026

About Synthaverse

Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents for use in oncology, gynecology, hematology, immunology, and related therapeutic areas in Poland, the rest of the European Union, and internationally. The company operates through the BCG and Traditional segments. The company offers OnkoBCG 50 and 100, which are oncological immunotherapy products used to treat superficial and non-invasive bladder tumors; GAMMA anti-D 50 and GAMMA anti-D 150, which are human anti-rh... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1944

Employees 214

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 6NQ

Financial Performance

Financial numbers in PLN Financial Statements